Colton Medical Weight Loss Center

Colton Medical Weight Loss Center operates as a physician-supervised weight management facility in Colton, California, under the clinical direction of Dr. Symonett. The practice focuses exclusively on medical weight loss interventions, with particular emphasis on GLP-1 receptor agonist therapy using semaglutide and tirzepatide. Unlike general wellness clinics that offer weight loss as one of many services, this center structures its entire clinical model around evidence-based pharmacological weight management protocols combined with metabolic assessment and lifestyle modification support. Patients receive in-person consultations at the Colton facility, where treatment plans are developed based on individual metabolic profiles, weight loss goals, and medical history.

Colton Medical Weight Loss Center's peptide therapy menu includes Semaglutide, and Tirzepatide, with treatment protocols customized based on individual health goals and lab work. Additional peptide options may be available based on medical necessity and FDA guidelines.

Dr. Symonett brings clinical expertise in obesity medicine to the Colton practice, conducting initial consultations that include medical history review, current medication assessment, weight loss goal discussion, and evaluation of contraindications for GLP-1 therapy. The center's approach involves establishing realistic weight loss targets, educating patients on the mechanisms of action for semaglutide and tirzepatide, and providing guidance on dietary modifications that complement pharmacological intervention. Patients receive instruction on proper injection technique, needle disposal, medication storage, and recognition of adverse effects requiring clinical attention. The practice maintains a structured follow-up schedule to assess treatment efficacy, adjust dosing protocols, and address any complications or concerns that arise during the weight loss process.

Patients attending Colton Medical Weight Loss Center can expect in-person visits at the California location, where they meet directly with Dr. Symonett and clinical staff for assessments and treatment planning. The center does not offer telehealth services, requiring all consultations and follow-up appointments to occur on-site in Colton. Initial visits typically involve body composition analysis, discussion of previous weight loss attempts, review of comorbid conditions such as diabetes or hypertension, and determination of appropriate peptide therapy. Subsequent appointments focus on weight tracking, side effect management, and behavioral counseling to support long-term weight maintenance. The practice has accumulated 32 Google reviews with a 4.4-star rating, with patient feedback frequently referencing the structured nature of the program and the clinical effectiveness of the treatments provided.

What distinguishes this center within the San Bernardino County medical weight loss landscape is its concentrated focus on peptide-based interventions rather than a broad menu of wellness services. The practice does not advertise comprehensive hormone replacement, IV therapy, or aesthetic treatments, instead channeling clinical resources specifically toward semaglutide and tirzepatide protocols for weight reduction. This specialization allows Dr. Symonett to maintain deep clinical familiarity with GLP-1 therapy nuances, including management of plateau phases, strategies for patients with medication resistance, and protocols for transitioning between different peptide formulations. For Colton-area residents seeking physician-supervised access to these specific weight loss medications with in-person clinical oversight, the center provides a geographically accessible option within the Inland Empire region of Southern California.